You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hyperoxaluria, Primary

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Hyperoxaluria Type 1 (PH1) Trial (Nedosiran)

Available
  • Primary Hyperoxaluria Type 1 (PH1)
  • (no location specified)
Aug 7, 2023

Cystinosis, Primary Hyperoxaluria Trial in Hanover (Diagnostic test)

Recruiting
  • Cystinosis
  • Primary Hyperoxaluria
  • Diagnostic test
  • Hanover, Lower Saxony, Germany
    Screening Laboratory Hanover
Apr 24, 2023

PH1, Primary Hyperoxaluria, RNAi Therapeutic Trial in Worldwide (Lumasiran)

Active, not recruiting
  • PH1
  • +4 more
  • Bordeaux, France
  • +8 more
Jan 13, 2023

Rare Kidney Stone Consortium Patient Registry

Recruiting
  • Primary Hyperoxaluria
  • +3 more
    • Rochester, Minnesota
    • +3 more
    Aug 19, 2022

    Study of Patients With Primary Hyperoxaluria Type 1 (PH1)

    Recruiting
    • Primary Hyperoxaluria Type 1
      • Phoenix, Arizona
      • +10 more
      Aug 11, 2022

      Phenotyping of Primary Hyperoxaluria

      Recruiting
      • Primary Hyperoxaluria
        • Strasbourg, France
          Service de Néphrologie et Transplantation - Hôpitaux Universitai
        Oct 25, 2021

        Primary Hyperoxaluria Trial in Bonn (Oxalobacter formigenes)

        Completed
        Has Results
        • Primary Hyperoxaluria
        • Oxalobacter formigenes
        • Bonn, Germany
          Universitätsklinikum Bonn, Department of Paediatric Nephrology
        Dec 9, 2021

        Primary Hyperoxaluria, Cystinuria, Adenine Phosphoribosyl Transferase Deficiency Trial in Rochester, New York, Reykjavik

        Completed
        • Primary Hyperoxaluria
        • +3 more
        • Health-related Quality of Life in Rare Kidney Stone Questionnaire
        • Rochester, Minnesota
        • +2 more
        Aug 31, 2022

        Hyperoxaluria, Primary Trial in Worldwide (Oxabact OC5 - Oxalobacter formigenes Strain HC-1)

        Terminated
        Has Results
        • Hyperoxaluria, Primary
        • Oxabact OC5 - Oxalobacter formigenes Strain HC-1
        • Nashville, Tennessee
        • +7 more
        Nov 11, 2021

        Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases Trial in Worldwide (DCR-PHXC)

        Enrolling by invitation
        • Primary Hyperoxaluria Type 1 (PH1)
        • +5 more
        • San Francisco, California
        • +19 more
        Jun 22, 2022

        Primary Hyperoxaluria, Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 2 Trial in Worldwide (nedosiran)

        Not yet recruiting
        • Primary Hyperoxaluria
        • +2 more
        • (no location specified)
        Sep 8, 2021

        Primary Hyperoxaluria Type 1 (PH1) Trial in Worldwide (Placebo, Lumasiran)

        Active, not recruiting
        Has Results
        • Primary Hyperoxaluria Type 1 (PH1)
        • San Diego, California
        • +15 more
        Mar 4, 2022

        Primary Hyperoxaluria Trial in Worldwide (Oxabact OC5 - Oxalobacter formigenes HC-1, Placebo)

        Completed
        Has Results
        • Primary Hyperoxaluria
        • Oxabact OC5 - Oxalobacter formigenes HC-1
        • Placebo
        • Nashville, Tennessee
        • +9 more
        Dec 9, 2021

        Rare Kidney Stone Consortium Biobank

        Recruiting
        • Primary Hyperoxaluria
        • +3 more
          • Rochester, Minnesota
            Mayo Clinic
          Jul 8, 2021

          Primary Hyperoxaluria Type 3 Trial in Worldwide (DCR-PHXC, Sterile Normal Saline (0.9% NaCl))

          Completed
          • Primary Hyperoxaluria Type 3
          • Boston, Massachusetts
          • +5 more
          Sep 9, 2021

          Primary Hyperoxaluria Trial in Paris (stiripentol (Diacomit))

          Completed
          • Primary Hyperoxaluria
          • stiripentol (Diacomit)
          • Paris, France
          • +2 more
          Mar 25, 2021

          Primary Hyperoxaluria Type 3 Trial in Worldwide

          Recruiting
          • Primary Hyperoxaluria Type 3
            • Boston, Massachusetts
            • +12 more
            Nov 16, 2021

            Primary Hyperoxaluria, Primary Hyperoxaluria Type 2, End Stage Renal Disease Trial in Spain, United Kingdom, United States

            Recruiting
            • Primary Hyperoxaluria
            • +2 more
            • Rochester, Minnesota
            • +4 more
            Jul 7, 2021

            Enteric Hyperoxaluria, Primary Hyperoxaluria, Hyperoxalemia Trial in Germany, United Kingdom, United States (ALLN-177)

            Completed
            • Enteric Hyperoxaluria
            • +2 more
            • Scottsdale, Arizona
            • +8 more
            Dec 29, 2020

            Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

            Recruiting
            • Adenine Phosphoribosyltransferase Deficiency
            • +83 more
              • Bristol, South West, United Kingdom
                Zoe Plummer
              Sep 26, 2023

              Baby Detect : Genomic Newborn Screening

              Recruiting
              • Congenital Adrenal Hyperplasia
              • +126 more
                • Liege, Wallonia, Belgium
                  CRMN, Hôpital La Citadelle
                Jan 24, 2023

                Primary Hyperoxaluria Type 1 (PH1) Trial in Worldwide (Lumasiran, Placebo)

                Completed
                Has Results
                • Primary Hyperoxaluria Type 1 (PH1)
                • Bordeaux, France
                • +8 more
                Jan 22, 2020

                Hyperoxaluria, Nonalcoholic Fatty Liver Disease, Kidney Stone Trial in United States (BMN 255, Placebo)

                Recruiting
                • Hyperoxaluria
                • +2 more
                • BMN 255
                • Placebo
                • Birmingham, Alabama
                • +6 more
                Nov 16, 2023

                Primary Hyperoxaluria Trial in Worldwide (DCR-PHXC, Placebo)

                Completed
                • Primary Hyperoxaluria
                • Boston, Massachusetts
                • +6 more
                Jan 17, 2020

                Prospective Research Rare Kidney Stones (ProRKS)

                Recruiting
                • Hyperoxaluria
                • +4 more
                  • Birmingham, Alabama
                  • +10 more
                  Nov 10, 2022